Rithm Capital Corp. Enters Underwriting Agreement for Series E Preferred Stock Sale

Reuters
Sep 23
<a href="https://laohu8.com/S/RITMV">Rithm Capital Corp.</a> Enters Underwriting Agreement for Series E Preferred Stock Sale

Rithm Capital Corp. has announced the entry into a material definitive agreement with Morgan Stanley & Co. LLC, acting as the representative of a group of underwriters. Under this agreement, dated September 18, 2025, Rithm Capital Corp. will sell 7,600,000 shares of its 8.750% Series E Fixed-Rate Cumulative Redeemable Preferred Stock at a par value of $0.01 per share, with a liquidation preference of $25.00 per share. The offering is expected to close on September 25, 2025, subject to customary conditions. The company has also provided the underwriters with a 30-day option to purchase an additional 1,140,000 shares. The net proceeds from this offering are intended for investments and general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rithm Capital Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-25-035580), on September 19, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10